Townhall + Tv

Login

Healthcare

Rhinomed continues to invest in furthering our knowledge of the role the nose|MICHAEL JOHNSON,MANAGING DIRECTOR,Rhinomed Ltd

The diagnostic tests will differentiate between squamous and non-squamous non-small cell lung cancer|Robert Wassman, MD,Rosetta Genomics Ltd

Developing next generation kinase inhibitors for autoimmune disease & cancer|Tim Mitchell, CEO, Sareum Holdings plc

Pioneering prediction and prevention in dermatology|Pia Renaudin, CEO,SciBase Holdings

Sernova is a regenerative medicine therapeutics company|Dr. Philip M. Toleikis,CTO,Sernova Corp

committed to developing next-generation precision diagnostics and exosome solutions|Dr Gregory Rice,Chief Scientific Officer,Sienna Cancer Diagnostics Ltd

Sirona Biochem is a cosmetic ingredient and drug discovery firm with a proprietary technology|Géraldine Deliencourt-Godefro,CSO,Sirona Biochem Corp

SkinBioTherapeutics is targeting five specific skin healthcare sectors|Stuart Ashman,Chief Executive,Skinbiotherapeutics

Rising to the challenges of rare disease treatment|Christopher J. Schaber,Chairman,Soligenix Inc

AI-powered software for personalized screening and early detection of breast cancer|Teri Thomas,Chief Executive Officer,Volpara Health Technologies Ltd

Advancing Innovative Immune-Oncology Technologies|Jeffrey F. Eisenberg,Chief Executive Officer,Xenetic Biosciences Inc

PROVIDES BREAKTHROUGH ONCOLOGICAL DRUG CANDIDATES|JOHAN EMILSSON, Chief Executive Officer,Sprint Bioscience

Breakthrough Science for Severe Viral Lung Infections|Richard Marsden,Chief Executive Officer,Synairgen

Company will focus on the continued development and commercialization of T cell therapies|Peter L. Hoang,CEO,TapImmune Inc

A TOTAL SOLUTION FROM EXTRACTION TO DETECTION|Dr. Chang, Chairman,TBG Diagnostics Ltd

Developing new treatment options for cancer patients in indications with the greatest medical need|Bill Welch, CEO, Trovagene Inc

«
1
2
...
51
52
53
54
55
56
57
...
68
69
»